KR900017572A - 필름 피복 정제 - Google Patents
필름 피복 정제 Download PDFInfo
- Publication number
- KR900017572A KR900017572A KR1019890006387A KR890006387A KR900017572A KR 900017572 A KR900017572 A KR 900017572A KR 1019890006387 A KR1019890006387 A KR 1019890006387A KR 890006387 A KR890006387 A KR 890006387A KR 900017572 A KR900017572 A KR 900017572A
- Authority
- KR
- South Korea
- Prior art keywords
- tablet
- film coating
- polymer film
- weight
- hpmc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 히드록시프로필 메틸셀룰로오스(HPMC) 및 트리아세틴으로 구성되는 중합체 필름으로 피복한 라니티딘염산염 정제.
- 제1항에 있어서,중합체 필름 피복제의 트리아세틴 함량이 HPMC 중량에 기초하여 5% 내지 25%인 정제.
- 제2항에 있어서,중합체 필름 피복제의 트리아세틴 함량이 10% 내지 15%인 정제.
- 제1항 내지 3항중 어느 한항에 있어서, 중합체 필름 피복제가 또한 1종 이상의 착색제 또는 유백제를 함유하는 정제.
- 제4항에 있어서, 중합체 필름 피복제중 착색제 또는 유백제의 양이 HPMC중량에 기초하여 5% 내지 65%인 정제.
- 제1항 내지 5항중 어느 한항에 있어서, 중합체 필름 피복물이 정제 100중량부당 2.1 내지 5.0중량부로 구성된 정제.
- 제6항에 있어서,중합체 피복물이 정제 100중량부당 3.0 내지 4.0중량부로 구성된 정제.
- 제1 내지 7항중 어느 한 항에 있어서, 라니티딘 염산염 정제 코어에 HPMC 및 트리아세틴으로 구성되는 중합체 필름 피복 기술에 의해 도포시키는 것으로 되는 정제 제조 방법.
- 제8항에 있어서, 중합체 필름 피복제를 수용성 조건하에서 상기 제조하고 도포시키는 방법.
- 제8항에 있어서, 중합체 필름 피복제를 유기(비수용성)용매를 사용하여 제조하고 도포시키는 방법.※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US194,427 | 1988-05-13 | ||
US07/194,427 US4880636A (en) | 1988-05-13 | 1988-05-13 | Film coated tablet of ranitidine HCl |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900017572A true KR900017572A (ko) | 1990-12-19 |
KR0124791B1 KR0124791B1 (ko) | 1997-11-25 |
Family
ID=22717564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890006387A KR0124791B1 (ko) | 1988-05-13 | 1989-05-13 | 필름 피복 정제 |
Country Status (22)
Country | Link |
---|---|
US (1) | US4880636A (ko) |
JP (1) | JP2749368B2 (ko) |
KR (1) | KR0124791B1 (ko) |
AT (1) | AT398035B (ko) |
AU (1) | AU627728B2 (ko) |
BE (1) | BE1002164A3 (ko) |
CA (1) | CA1327164C (ko) |
CH (1) | CH678273A5 (ko) |
CY (1) | CY1639A (ko) |
DE (1) | DE3915575C2 (ko) |
DK (1) | DK170208B1 (ko) |
FR (1) | FR2631233B1 (ko) |
GB (1) | GB2218336B (ko) |
HK (1) | HK64892A (ko) |
IE (1) | IE60723B1 (ko) |
IL (1) | IL90278A (ko) |
IT (1) | IT1237410B (ko) |
NL (1) | NL192819C (ko) |
NZ (1) | NZ229097A (ko) |
SE (1) | SE501694C2 (ko) |
SG (1) | SG33492G (ko) |
ZA (1) | ZA893555B (ko) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2106818T3 (es) * | 1991-10-30 | 1997-11-16 | Glaxo Group Ltd | Composicion multicapa que contiene antagonistas de histamina o secotina. |
US5411746A (en) * | 1993-02-24 | 1995-05-02 | Warner-Jenkinson Company, Inc. | Dye compositions and methods for film coating tablets and the like |
DE4341310A1 (de) * | 1993-12-03 | 1995-06-08 | Hexal Pharma Gmbh | Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1 |
GB2285989A (en) * | 1994-01-28 | 1995-08-02 | Merck Frosst Canada Inc | Aqueous formulations for enteric coatings |
US5407687A (en) * | 1994-02-22 | 1995-04-18 | Glaxo Inc. | Ranitidine solid dosage form |
DK171127B1 (da) * | 1994-04-22 | 1996-06-24 | Gea Farmaceutisk Fabrik As | Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk |
EP0773866B1 (de) * | 1994-08-03 | 1998-04-08 | Gunter Meinhardt Voss | Verfahren zur herstellung von manteltabletten |
US5538737A (en) * | 1994-11-30 | 1996-07-23 | Applied Analytical Industries, Inc. | Oral compositions of H2 -antagonists |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
PA8576201A1 (es) * | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
US7727549B2 (en) | 2002-07-15 | 2010-06-01 | Alcon, Inc. | Pharmaceutical compositions for otic use |
CA2491312C (en) * | 2002-07-15 | 2011-05-31 | Alcon, Inc. | Bioerodible film for ophthalmic drug delivery |
US7429619B2 (en) | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
US20070281022A1 (en) * | 2004-10-27 | 2007-12-06 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088593A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20070190133A1 (en) * | 2004-10-27 | 2007-08-16 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US8383159B2 (en) * | 2004-10-27 | 2013-02-26 | Mcneil-Ppc, Inc. | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088587A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060087051A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060088586A1 (en) * | 2004-10-27 | 2006-04-27 | Bunick Frank J | Dosage forms having a microreliefed surface and methods and apparatus for their production |
US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
WO2008042802A2 (en) * | 2006-09-29 | 2008-04-10 | Sensient Pharmaceutical Technologies Inc. | Wet edible pearlescent film coatings |
EP2099312B1 (en) * | 2006-12-14 | 2016-05-04 | Sensient Colors LLC | Pearlescent pigment compositions and methods for making and using the same |
CN111686087A (zh) * | 2020-07-27 | 2020-09-22 | 瑞阳制药有限公司 | 含ndma杂质低的盐酸雷尼替丁片的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2816062A (en) * | 1954-05-27 | 1957-12-10 | Univ Illinois | Hydroxyethyl cellulose tablet coating |
GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
US4274830A (en) * | 1977-09-27 | 1981-06-23 | Colorcon, Inc. | Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products |
JPS5598120A (en) * | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
EP0065823A1 (en) * | 1981-05-13 | 1982-12-01 | Imperial Chemical Industries Plc | Heterocyclic guanidines as histamine H-2 antagonists |
KR840000624A (ko) * | 1982-06-02 | 1984-02-25 | 원본미기재 | 부식억제 페인트 조성물 |
EP0096982B1 (en) * | 1982-06-10 | 1987-09-16 | Imperial Chemical Industries Plc | Manufacture of highlighted intagliated articles |
GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
GB8414220D0 (en) * | 1984-06-04 | 1984-07-11 | Sterwin Ag | Medicaments in unit dose form |
US4629620A (en) * | 1984-09-05 | 1986-12-16 | Ab Ferrosan | Membrane-coated sustained-release tablets and method |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
US4704285A (en) * | 1985-11-18 | 1987-11-03 | The Dow Chemical Company | Sustained release compositions comprising hydroxypropyl cellulose ethers |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
US4795641A (en) * | 1987-08-20 | 1989-01-03 | Eastman Kodak Company | Polymer blends having reverse phase morphology for controlled delivery of bioactive agents |
-
1988
- 1988-05-13 US US07/194,427 patent/US4880636A/en not_active Expired - Lifetime
-
1989
- 1989-05-12 NL NL8901199A patent/NL192819C/nl not_active IP Right Cessation
- 1989-05-12 FR FR8906277A patent/FR2631233B1/fr not_active Expired - Fee Related
- 1989-05-12 DE DE3915575A patent/DE3915575C2/de not_active Revoked
- 1989-05-12 IL IL90278A patent/IL90278A/xx not_active IP Right Cessation
- 1989-05-12 NZ NZ229097A patent/NZ229097A/xx unknown
- 1989-05-12 ZA ZA893555A patent/ZA893555B/xx unknown
- 1989-05-12 CA CA000599589A patent/CA1327164C/en not_active Expired - Fee Related
- 1989-05-12 JP JP1120190A patent/JP2749368B2/ja not_active Expired - Fee Related
- 1989-05-12 SE SE8901722A patent/SE501694C2/sv not_active IP Right Cessation
- 1989-05-12 AU AU34747/89A patent/AU627728B2/en not_active Ceased
- 1989-05-12 BE BE8900517A patent/BE1002164A3/fr not_active IP Right Cessation
- 1989-05-12 IE IE156489A patent/IE60723B1/en not_active IP Right Cessation
- 1989-05-12 AT AT0114389A patent/AT398035B/de not_active IP Right Cessation
- 1989-05-12 DK DK233789A patent/DK170208B1/da not_active IP Right Cessation
- 1989-05-12 IT IT8947953A patent/IT1237410B/it active
- 1989-05-12 CH CH1791/89A patent/CH678273A5/fr not_active IP Right Cessation
- 1989-05-12 GB GB8910941A patent/GB2218336B/en not_active Expired - Lifetime
- 1989-05-13 KR KR1019890006387A patent/KR0124791B1/ko not_active IP Right Cessation
-
1992
- 1992-03-19 SG SG33492A patent/SG33492G/en unknown
- 1992-08-27 HK HK648/92A patent/HK64892A/xx not_active IP Right Cessation
- 1992-11-06 CY CY1639A patent/CY1639A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900017572A (ko) | 필름 피복 정제 | |
KR880000088A (ko) | 지속적인 방출 제제 | |
KR900002769A (ko) | 장시간 작용하는 나트륨 디클로페낙의 제제 | |
KR890001626A (ko) | Fr-900506 물질의 고체 분산 조성물 | |
KR920002135A (ko) | 대장에서만 방출할수 있는 피복시킨 고체 약물형태 | |
KR870000069A (ko) | 안정한 고체 제형의 제조 방법 | |
KR890004689A (ko) | 니트로글리세린 스프레이 | |
CO4700410A1 (es) | Base formadora de pelicula que contiene polimeros y solven- tes | |
KR890014095A (ko) | 방출 제어형 약제 및 그의 제조방법 | |
JP2001521910A5 (ko) | ||
KR950701214A (ko) | 눈에 투여를 위한 약제학적 투약 형태 및 그 제조방법(galenic form for ocular administraion and process for the preparation of same) | |
KR900018321A (ko) | 액체 유기수소폴리실록산을 함유하는 가교결합 가능한 감압성 접착제 | |
KR910003606A (ko) | 광중합성 기록물질 | |
KR890009385A (ko) | 피막 형성성 항진균제 조성물 | |
KR890700020A (ko) | 서방성과립 및 그를 함유하는 지속성 복합과립 | |
KR910021361A (ko) | 항궤양 물질 | |
KR900013945A (ko) | 건조제 타블렛 | |
JPS53133625A (en) | Manufacturing of pharmaceutical coated with enteric film | |
BR0003356A (pt) | Agente de revestimento contendo substância de celulose assim como seu emprego em lacas | |
KR950007838A (ko) | 은행잎 엑기스 연질캅셀제 및 그의 제조방법 | |
JPS53102993A (en) | Pruduction of powdered cationic carbamoyl polymer | |
KR930000035A (ko) | 파프리카 올레오레진 미세캡슐 및 그의 제조방법 | |
IT7922109A0 (it) | Perfezionamenti a procedimento per la preparazione di corpi formati di cellulosa rigenerata da soluzioni di derivati dalla cellulosa in solventi organici. | |
ATE115565T1 (de) | 2-halogensubstituierte n-indolylethyl- sulfonsäureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
KR910019605A (ko) | 항진균성 겔제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030718 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |